ArticleBone marrow transplantation2022

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT).

Enrico Maffini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.